TerminatedPHASE1, PHASE2NCT01009801

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Studying Adult hepatocellular carcinoma

Last synced from ClinicalTrials.gov May 3, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Swiss Cancer Institute
Principal Investigator: Jean-Francois Dufour, MD, M.D., Ph.D
Insel Gruppe AG, University Hospital Bern
Intervention: doxorubicin-eluting beads(drug)
Enrollment: 27 enrolled
Eligibility: 18 years · All sexes
Timeline: 2010 – 2015

Study locations (8)

Inselspital Bern, Bern, Switzerland
Kantonsspital Graubuenden, Chur, Switzerland
Hopital Cantonal Universitaire de Geneve, Geneva, Switzerland
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Clinica Luganese di Moncucco, Lugano, Switzerland
Kantonsspital - St. Gallen, Sankt Gallen, Switzerland
Institut Central des Hopitaux Valaisans / Hôpital de Sion, Sion, Switzerland
UniversitaetsSpital Zuerich, Zurich, Switzerland

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01009801 on ClinicalTrials.gov

Other trials for Adult hepatocellular carcinoma

Additional recruiting or active studies for the same condition.

See all trials for Adult hepatocellular carcinoma →

← Back to all trials